Tracing Inherited Central Vision Loss Through the Family Tree
A house key copied many times over the years, each new copy cut from the last rather than the original, doesn't always turn a lock quite the same way — some fit perfectly, others need a firm wiggle to catch. Hereditary macular dystrophies pass through families in a rather similar way: the same faulty gene handed down across generations doesn't necessarily behave identically in every relative who ends up carrying it.
For Ugandan families where several relatives share the same diagnosis but at noticeably different ages, or with noticeably different severity, that unevenness usually isn't a sign anything's been mixed up. Far more often, it's exactly the kind of detail a properly taken family history is meant to bring to light.
Loss of central, detailed vision over time links every hereditary macular dystrophy, but that's roughly where the similarities end — the age it starts and the speed it moves at can look dramatically different even between two siblings with the identical mutation. One might struggle to read a menu by seventeen, while a brother or sister carrying the exact same faulty gene copy might see perfectly clearly for another fifteen years. Doctors call this variable expressivity, and without an explanation, it tends to leave families thoroughly puzzled.
Practically every hereditary macular dystrophy can be traced to one of three inheritance routes, and spotting which route applies is usually the fastest shortcut to a diagnosis. A dominant condition only needs one faulty copy to act, so it tends to reappear generation after generation without a break. A recessive one needs two faulty copies working together, so it can lie dormant through an entire generation before suddenly showing up once two carriers happen to marry. And when the fault sits on the X chromosome, it's typically sons who bear the worst of it, while daughters carry the same fault forward with comparatively little effect on themselves.
We combine genetic testing with a careful, methodical look at the family's history — establishing who has been affected, when symptoms first appeared for each of them, and how serious each case turned out to be. Even relatives with no complaints at all are often brought in for testing, since someone who feels completely healthy might still be a silent carrier, a fact with real consequences for anyone thinking ahead to their own children. Once the pattern of inheritance points toward a probable cause, imaging — OCT paired with an ERG — confirms just how far the disease has actually progressed.
The exact dystrophy uncovered through testing is what really drives the treatment strategy, though a hereditary diagnosis adds something extra to think about — namely, extending support and conversation to the wider family rather than stopping at the one patient in front of us. That often includes flagging relatives who might benefit from being screened themselves, and, where it's genuinely appropriate, connecting the family with a certified genetic counsellor before any decisions are made about having more children.
Not a problem at all — this is simply variable expressivity showing itself, where identical genetic faults can produce noticeably different results in different people. It doesn't cast doubt on either diagnosis; it's just a reminder that a shared gene doesn't guarantee a shared outcome.
Usually, yes — once we know the exact gene at fault and how it's inherited, a certified counsellor can walk you through roughly what the odds look like for children going forward. Given how much weight that conversation carries, we'd suggest having it directly with a counsellor rather than relying on secondhand advice.
Quite likely, actually, especially if we're dealing with a recessive condition, where a parent can carry a single faulty copy for a lifetime and never notice a thing. The disease only becomes visible once both copies a child inherits are faulty, which is exactly why two healthy-looking parents can still have an affected child.
It frequently does, particularly for conditions where variable expressivity is already well documented, since someone can carry the exact mutation and show absolutely nothing outwardly. A simple baseline exam establishes where they stand and answers the carrier question for anyone planning a family down the line.